Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
Earnings Data
Report Date
Nov 05, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.03Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in revenue, international expansion, and positive developments in product pipelines and cash flow management. However, the gross margin decline and anticipated challenges with U.S. distributor inventory reductions present areas of concern. Overall, the positive aspects significantly outweigh the negatives.Company Guidance
Record Revenue Milestone
KORU Medical Systems achieved over $10 million in revenue for Q2 2025, marking more than a 20% year-over-year growth.
Significant International Expansion
International revenues grew by 34%, driven by expansion into new geographies and success with the prefilled syringe strategy in Europe.
Pharma Services and Clinical Trials Growth
The Pharma Services and Clinical Trials segment saw a 42% growth, driven by clinical trial orders from a non-Ig partner.
FDA Approvals and Submissions
FDA approved an expanded indication for Empaveli, and a 510(k) submission was made ahead of schedule for a rare disease biologic.
Positive Cash Flow Trajectory
Q2 cash usage was reduced to $600,000, with expectations for neutral to positive cash flow in the second half of 2025.
Next-Generation Product Developments
Launched Phase I flow controller ahead of schedule and on track with next-gen pump development, with a 510(k) submission expected by Q4 2025 to Q1 2026.
KRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
KRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $3.26 | $3.87 | +18.71% |
May 07, 2025 | $2.72 | $3.29 | +20.96% |
Mar 12, 2025 | $3.28 | $2.70 | -17.68% |
Nov 13, 2024 | $3.20 | $3.08 | -3.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does REPRO-MED Systems (KRMD) report earnings?
REPRO-MED Systems (KRMD) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).
What is REPRO-MED Systems (KRMD) earnings time?
REPRO-MED Systems (KRMD) earnings time is at Nov 05, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KRMD EPS forecast?
KRMD EPS forecast for the fiscal quarter 2025 (Q3) is -0.02.